Latest Asx News

Island Pharmaceuticals has completed dosing in the Phase 2b cohort of its dengue fever trial, with pharmacokinetic targets met and top-line results expected next month. The company also strengthened its balance sheet by raising $1.94 million through option exercises.

PeopleIn Limited reported a $6.3 million Q3 FY25 EBITDA, down from $6.9 million last year, affected by severe weather in Queensland. Strong cash flow helped reduce debt, underscoring resilience despite ongoing trading challenges.

CurveBeam AI reported a robust 40% increase in purchase orders during Q3 FY25 and secured a non-binding A$18 million vendor financing term sheet, positioning the company for cashflow positivity in Q4.

CurveBeam AI Limited reported a $4.367 million net operating cash outflow for Q3 2025 but anticipates a significant improvement in cash flow driven by device installations and customer receipts, with no immediate plans for capital raising.

Tryptamine Therapeutics has secured a landmark agreement with Swinburne University to initiate the first clinical trial of its IV-infused psilocin formulation TRP-8803 for Binge Eating Disorder, aiming to build on promising Phase 2a data.

Southern Palladium’s March quarter report highlights strong project economics from its Bengwenyama PGM project, with a $1.06 billion NPV and a mining right decision expected in Q2 2025. The company is progressing a Definitive Feasibility Study and project optimisation to accelerate production.

Amplia Therapeutics has completed recruitment early for its Phase 2a ACCENT trial in advanced pancreatic cancer, reporting encouraging interim results and advancing a second trial with FDA-backed protocol changes.

Ecofibre Limited reported a $2.2 million operating cash outflow in 3Q25 with total cash at $1.3 million, highlighting mixed progress across its business units and a pressing need to monetise assets to sustain operations.

Pancontinental Energy reports a significant 3.8 billion barrels of net prospective oil resources at its Saturn Complex in Namibia’s PEL 87, advancing farmout talks and environmental approvals for exploration drilling.

Middle Island Resources completed analysis of its maiden drilling at the Georgina Project and secured three new exploration permits in Queensland, while renewing its board with two new directors post-quarter.

Critical Resources Limited reports significant exploration breakthroughs at its Halls Peak Project in NSW, identifying over 30 new antimony-gold targets and confirming high-grade mineralisation at Mayview. Concurrently, lithium drilling at Mavis Lake in Canada delivers promising results, supported by a partial $1.1 million capital raise.

Infini Resources reports promising uranium assays from maiden drilling at Falls Lake and completes key Athabasca Basin acquisitions, backed by a $3.4 million Canadian capital raise.